-
Uncategorized4 weeks ago
Unlocking more value from mature drug products through strategic outsourcing
See how strategic outsourcing can maximize value and reduce costs for mature drug portfolios. Read More
-
Uncategorized4 weeks ago
Can Revolution’s ‘miracle’ pancreatic cancer drug be topped? Immuneering, Actuate say yes
Last month, Revolution Medicines’ RAS inhibitor doubled survival in a Phase 3 pancreatic cancer trial. On the biotech’s heels are Immuneering, Actuate Therapeutics, Erasca and more,...
-
Uncategorized4 weeks ago
4 spaces primed for the next wave of gene therapies
4 spaces primed for the next wave of gene therapies
-
Uncategorized4 weeks ago
FDA alignment is critical to serving the rare disease community. AI can help
The FDA has introduced models intended to accelerate rare disease drug development, but recent reversals of guidance from the agency speak to a lack of clarity...
-
Uncategorized4 weeks ago
Ardent Health taps Fujifilm’s AI-enabled patient imaging platform
Fujifilm Healthcare Americas Corp. has signed a deal with Ardent Health to bring its enterprise imaging software to hospitals and clinics in six states.Read More
-
Uncategorized4 weeks ago
StockWatch: Regenxbio Tumbles Despite Positive Pivotal Data for DMD Gene Therapy Candidate
StockWatch: Regenxbio Tumbles Despite Positive Pivotal Data for DMD Gene Therapy Candidate
-
Uncategorized4 weeks ago
Potato pests
Nature Biotechnology, Published online: 18 May 2026; doi:10.1038/s41587-026-03133-0 Potato pests
-
Uncategorized4 weeks agoSTAT+: U.K. advocacy groups threaten court action over a key provision in the pharma trade deal with the U.S.
Two advocacy groups are demanding the United Kingdom revoke regulations at the heart of a new trade agreement with the U.S. over concerns the deal will...
-
Uncategorized4 weeks agoIn Ebola outbreak, a number of Americans in the Congo believed to have had exposure to suspected cases
A number of Americans who are in the Democratic Republic of the Congo are believed to have had exposure to suspected cases in the country’s latest...
-
Uncategorized4 weeks agoWhen should you get a mammogram? Conflicting advice makes it hard to know
WASHINGTON — Deciding when to get routine mammograms is confusing. Some health groups recommend women begin at age 40 or 45 while another recently opted for age 50....
STAT+: Up and down the ladder: The latest comings and goings
FDA imposes import alert on Indian plant after inspectors flag GMP failings
